205 related articles for article (PubMed ID: 29791878)
1. Computational design of antibodies.
Fischman S; Ofran Y
Curr Opin Struct Biol; 2018 Aug; 51():156-162. PubMed ID: 29791878
[TBL] [Abstract][Full Text] [Related]
2. Toward rational antibody design: recent advancements in molecular dynamics simulations.
Yamashita T
Int Immunol; 2018 Apr; 30(4):133-140. PubMed ID: 29346652
[TBL] [Abstract][Full Text] [Related]
3. Optimizing properties of antireceptor antibodies using kinetic computational models and experiments.
Harms BD; Kearns JD; Su SV; Kohli N; Nielsen UB; Schoeberl B
Methods Enzymol; 2012; 502():67-87. PubMed ID: 22208982
[TBL] [Abstract][Full Text] [Related]
4. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
5. Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope.
Azoitei ML; Ban YE; Julien JP; Bryson S; Schroeter A; Kalyuzhniy O; Porter JR; Adachi Y; Baker D; Pai EF; Schief WR
J Mol Biol; 2012 Jan; 415(1):175-92. PubMed ID: 22061265
[TBL] [Abstract][Full Text] [Related]
6. Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays.
Duquesnoy RJ; Marrari M; Jelenik L; Zeevi A; Claas FH; Mulder A
Hum Immunol; 2013 Oct; 74(10):1271-9. PubMed ID: 23770250
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of potential sites for antibody engineering by fluctuation editing.
Yanaka S; Moriwaki Y; Tsumoto K; Sugase K
Sci Rep; 2017 Aug; 7(1):9597. PubMed ID: 28855581
[TBL] [Abstract][Full Text] [Related]
8. Antibodies Targeting Closely Adjacent or Minimally Overlapping Epitopes Can Displace One Another.
Abdiche YN; Yeung AY; Ni I; Stone D; Miles A; Morishige W; Rossi A; Strop P
PLoS One; 2017; 12(1):e0169535. PubMed ID: 28060885
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
10. Toward Drug-Like Multispecific Antibodies by Design.
Sawant MS; Streu CN; Wu L; Tessier PM
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053650
[TBL] [Abstract][Full Text] [Related]
11. Affinity maturation of antiHER2 monoclonal antibody MIL5 using an epitope-specific synthetic phage library by computational design.
Qiao C; Lv M; Li X; Geng J; Li Y; Zhang J; Lin Z; Feng J; Shen B
J Biomol Struct Dyn; 2013; 31(5):511-21. PubMed ID: 23003339
[TBL] [Abstract][Full Text] [Related]
12. OptMAVEn--a new framework for the de novo design of antibody variable region models targeting specific antigen epitopes.
Li T; Pantazes RJ; Maranas CD
PLoS One; 2014; 9(8):e105954. PubMed ID: 25153121
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
[TBL] [Abstract][Full Text] [Related]
14. Ab-Ligity: identifying sequence-dissimilar antibodies that bind to the same epitope.
Wong WK; Robinson SA; Bujotzek A; Georges G; Lewis AP; Shi J; Snowden J; Taddese B; Deane CM
MAbs; 2021; 13(1):1873478. PubMed ID: 33448242
[TBL] [Abstract][Full Text] [Related]
15. Potential of mean force for Syrian hamster prion epitope protein--monoclonal fab 3f4 antibody interaction studies.
Wang YT; Su ZY; Liao JM; Chen CL
Eur J Med Chem; 2009 Sep; 44(9):3504-8. PubMed ID: 19304354
[TBL] [Abstract][Full Text] [Related]
16. Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping.
Liu X; Taylor RD; Griffin L; Coker SF; Adams R; Ceska T; Shi J; Lawson AD; Baker T
Sci Rep; 2017 Jan; 7():41306. PubMed ID: 28128368
[TBL] [Abstract][Full Text] [Related]
17. Structure-Guided Design of Antibodies.
Caravella JA; Wang D; Glaser SM; Lugovskoy A
Curr Comput Aided Drug Des; 2010; 6(2):128-38. PubMed ID: 26845329
[TBL] [Abstract][Full Text] [Related]
18. [Avidity of polyreactive immunoglobulins].
Bobrovnik SA
Ukr Biochem J; 2014; 86(6):183-9. PubMed ID: 25816619
[TBL] [Abstract][Full Text] [Related]
19. Computational Tools for Aiding Rational Antibody Design.
Krawczyk K; Dunbar J; Deane CM
Methods Mol Biol; 2017; 1529():399-416. PubMed ID: 27914064
[TBL] [Abstract][Full Text] [Related]
20. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
